JA

JOYN Advisors Portfolio holdings

AUM $300M
1-Year Return 14.91%
This Quarter Return
+2.35%
1 Year Return
-14.91%
3 Year Return
-0.77%
5 Year Return
+5.98%
10 Year Return
AUM
$445M
AUM Growth
+$9.95M
Cap. Flow
+$16.3M
Cap. Flow %
3.67%
Top 10 Hldgs %
82.04%
Holding
138
New
21
Increased
65
Reduced
26
Closed
11
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ROST icon
101
Ross Stores
ROST
$50B
$239K 0.05%
2,365
-154
-6% -$15.6K
CARO
102
DELISTED
Carolina Financial Corp.
CARO
$235K 0.05%
+7,081
New +$235K
AVGO icon
103
Broadcom
AVGO
$1.44T
$234K 0.05%
8,750
+680
+8% +$18.2K
GSBD icon
104
Goldman Sachs BDC
GSBD
$1.31B
$232K 0.05%
12,000
SYY icon
105
Sysco
SYY
$39.3B
$232K 0.05%
3,460
-258
-7% -$17.3K
ABT icon
106
Abbott
ABT
$231B
$230K 0.05%
2,769
-80
-3% -$6.65K
CAT icon
107
Caterpillar
CAT
$196B
$230K 0.05%
1,889
+16
+0.9% +$1.95K
QCOM icon
108
Qualcomm
QCOM
$172B
$227K 0.05%
+3,294
New +$227K
UNP icon
109
Union Pacific
UNP
$132B
$227K 0.05%
1,359
+51
+4% +$8.52K
KIM icon
110
Kimco Realty
KIM
$15.4B
$219K 0.05%
11,692
-40
-0.3% -$749
SCHV icon
111
Schwab US Large-Cap Value ETF
SCHV
$13.2B
$218K 0.05%
12,057
NFLX icon
112
Netflix
NFLX
$533B
$217K 0.05%
707
+65
+10% +$20K
ESRT icon
113
Empire State Realty Trust
ESRT
$1.33B
$216K 0.05%
+16,397
New +$216K
BBY icon
114
Best Buy
BBY
$16.2B
$212K 0.05%
3,199
-161
-5% -$10.7K
CVS icon
115
CVS Health
CVS
$93.1B
$212K 0.05%
+3,896
New +$212K
GILD icon
116
Gilead Sciences
GILD
$140B
$211K 0.05%
+3,328
New +$211K
IYR icon
117
iShares US Real Estate ETF
IYR
$3.72B
$206K 0.05%
2,344
GD icon
118
General Dynamics
GD
$86.7B
$205K 0.05%
+1,161
New +$205K
EW icon
119
Edwards Lifesciences
EW
$47.4B
$203K 0.05%
2,910
-390
-12% -$27.2K
GLW icon
120
Corning
GLW
$59.9B
$202K 0.05%
7,163
+734
+11% +$20.7K
CGBD icon
121
Carlyle Secured Lending
CGBD
$1B
$193K 0.04%
13,194
CZR
122
DELISTED
Caesars Entertainment Corporation
CZR
$141K 0.03%
+12,138
New +$141K
GSKY
123
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$114K 0.03%
+10,969
New +$114K
GALT icon
124
Galectin Therapeutics
GALT
$298M
$43K 0.01%
12,796
RNTX
125
Rein Therapeutics, Inc. Common Stock
RNTX
$31.1M
$16K ﹤0.01%
1,500